Invention Grant
- Patent Title: Hepatitis C virus NS2/3 activity assay
- Patent Title (中): 丙型肝炎病毒NS2 / 3活性测定
-
Application No.: US11553531Application Date: 2006-10-27
-
Publication No.: US07655394B2Publication Date: 2010-02-02
- Inventor: Roger Maurice , Diane Thibeault
- Applicant: Roger Maurice , Diane Thibeault
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Mary-Ellen M. Devlin; David A. Dow
- Main IPC: C12Q1/00
- IPC: C12Q1/00

Abstract:
The invention provides a novel assay for NS2/3 cleavage detection, particularly, a novel assay for the detection of the NS3 cleavage product in the presence of uncleaved NS2/3 based on discrimination of the activity of the resulting NS3 protease product from the NS3 protease activity of the NS2/3 uncleaved protein. Certain reaction conditions allow this discrimination in situ without having to resort to physical separation of both proteases by decreasing the NS3 protease activity of the NS2/3 protein and increasing the NS3 protease activity of the resulting NS3 protease product, thereby producing a “signal window” upon which it is feasible to distinguish and measure NS3 protease activity produced from the cleavage of NS2/3.
Public/Granted literature
- US20070212754A1 Hepatitis C Virus NS2/3 Activity Assay Public/Granted day:2007-09-13
Information query